|
Market Cap (6-Jul) $758,238,016 (475th) |
Close (30-Jun) $0.056 |
Volume (30-Jun) 1,984,515 |
Shortsold (19-Jun) 895,750 (0.15%) (396th) |
|
52w High $2.09 |
52w Low $0.90 |
P/E - |
EPS -0.11 |
PYC released this announcement to the ASX on 17 March 2021, 10:10. The announcement is not marked as price sensitive, and is 2 page(s) in length and 227.18kb in size.
You can view all announcements from PYC and see how they appear on a price chart on the announcements page.
At the date of this announcement, PYC was 0.000% short sold according to ASIC data. It was ranked the 610th most shorted stock on the ASX. It is now ranked as the 396th most shorted stock on the ASX with 0.154% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from PYC | |
|---|---|
| FIRST PATIENT DOSED IN EYE DISEASE CLINICAL TRIAL | 30 June 2023, 8:17 |
| Change of Director's Interest Notice | 28 June 2023, 16:46 |
| PYC Investor Update Presentation | 16 June 2023, 8:32 |
| PYC Appoints US Biotech Veteran to its Board of Directors | 17 March 2021, 10:10 |
| Lead Investigational Drug Demonstrates Key Improvement | 2 March 2021, 8:21 |
| Half Year Accounts and Appendix 4D | 26 February 2021, 17:05 |
| PYC Expands US Executive Leadership Team | 23 February 2021, 9:38 |
You must be logged in to post a reply.
